iiCON: Infection Innovation Consortium

iiCON is a public-private consortium born out of the Liverpool City Region and backed by UKRI’s Strength in Places Fund. It has been established to fast-track the discovery and development of innovative new products and treatments for infectious diseases to positively impact global health. 

Led by the Liverpool School of Tropical Medicine (LSTM), iiCON brings together leading UK organisations focused on infectious disease R&D, including Liverpool University Hospitals NHS Foundation Trust, Unilever UK, the University of Liverpool, and Infex Therapeutics, Evotec, and the AMR Centre, which are based at Alderley Park, Cheshire.

To find out more, visit: www.infectioninnovation.com